venice i: venetoclax in r/r cll patients
Published 4 years ago • 414 plays • Length 4:38Download video MP4
Download video MP3
Similar videos
-
2:08
the venice-1 trial: venetoclax monotherapy in r/r cll
-
1:53
venice i: mrd response with venetoclax in r/r cll
-
0:49
venice ii trial: health-related qol in patients with cll treated with venetoclax
-
1:36
improve study update: safety and efficacy of venetoclax retreatment in r/r cll
-
2:05
results from the phase i sal-relax trial: venetoclax plus cytarabine and mitoxantrone in r/r aml
-
2:00
update of a phase i trial investigating lintuzumab-ac225 plus venetoclax in r/r aml
-
1:23
interim analysis of the flair study: efficacy of ibrutinib plus venetoclax in ighv unmutated cll
-
1:09
dec-c plus venetoclax in hr-mds and cmml: an analysis using different response criteria
-
2:49
results from the phase iii echo trial of acalabrutinib plus br in mcl
-
3:28
the sympatico trial: ibrutinib plus venetoclax in tp53-mutated mcl
-
4:44
7-year update on a phase ii trial of fixed-duration obinutuzumab, ibrutinib, and venetoclax for cll
-
1:12
cpx-351 with venetoclax in r/r aml: results of a phase ib study
-
1:03
10-day astx727 (decitabine/cedazuridine) with venetoclax in the treatment of r/r aml
-
3:09
bleximenib combined with venetoclax and azacitidine in r/r aml with kmt2a or npm1 alterations
-
3:37
sympatico: ibrutinib combined with venetoclax in patients with r/r mcl
-
2:00
obinutuzumab, ibrutinib, and venetoclax in high-risk cll: the cll2-give and cll13 trials
-
4:21
hovon 141/vision trial update: mrd-guided venetoclax ibrutinib treatment for r/r cll
-
2:08
the role of venetoclax in the treatment of cll
-
3:33
investigating the safety and efficacy of re-treating cll patients with venetoclax-based regimens
-
0:48
venetoclax and obinutuzumab for cll
-
1:52
evaluating the efficacy of obinutuzumab, ibrutinib, and venetoclax in richter's transformation
-
1:59
phase i study of pevonedistat, azacitidine, and venetoclax in patients with r/r aml